services-office-darkservices-office-light

Our services

How we can enlighten your business together

Levering allogeneic cells technologies, we provide safe, effective and affordable treatments for millions of patients worldwide. Through our open innovation model, we integrate the entire value chain, making us a one-stop partner to drive ATMP success from concept to commercialization. We cover the 3 types of ATMPs and the full spectrum of services needed to bring them to market.

ideeea-agacell_web_icon_XL_enlightning
ideeea-agacell_web_icons_dark_DNA

Gene Therapy Medicines

ideeea-agacell_web_icons_dark_CELL-02

Somatic-Cell Therapy Medicines

ideeea-agacell_web_ICONS_TISSUE

Tissue-Engineered Medicines

R&D
Intellectual Property
GMP Manufacturing
Preclinical & Clinical studies
Regulatory Affairs
Commercialization
R&D
Intellectual Property
GMP Manufacturing
Preclinical & Clinical studies
Regulatory Affairs
Commercialization
researcher_image

Researcher

If you have an idea, we can bring your research to project to market.

Which ideas do we choose?

  • Projects in biotech and advanced therapies
  • Focus on scalability and market potential
startup_image

Startup

We can co-develop and invest in new biotech products, bringing your project to the next level.

What can we offer you? We guide you along the whole value chain:

  • Expertise in IP and RA services
  • Support in Preclinical and Clinical studies
  • GMP manufacturing of ATMPs in our facilities
company_image

Established company

If you are interested in licensing opportunities or joint development in any territory, let’s talk.

What are you interested in?

  • Advanced Therapy Medicinal Products (ATMPs)
  • Dermatology
  • Immunology
  • Rare diseases
  • Cancer
investor_image

Investor

If you are looking for promising biotech opportunities with tangible market potential, let’s talk.

Are you interested in...

  • High-growth biotech opportunities
  • Partnering in breakthrough ATMPs
  • Long-term collaboration
  • Innovation-driven leadership

Subscribe to our newsletter and enlighten your inbox with our latest news!